Bio­phar­ma ven­ture fund­ing falls to the low­est to­tal since 2019 as star­tups pon­der al­ter­na­tive paths

Ven­ture cap­i­tal in­vest­ments in biotech and phar­ma hit a more than three-year low last quar­ter as a pro­longed mar­ket down­turn forced dif­fi­cult next-step de­ci­sions for …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.